Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 373, Issue 1742, 2018, Pages

  St Clair, David ^a   Johnstone, Mandy ^b,c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Autism; Mouse and iPSC models; Schizophrenia

Indexed keywords

BIOTECHNOLOGY; CELL; DISABILITY; GENETIC ENGINEERING; MOLECULAR ANALYSIS; MUTATION; NERVOUS SYSTEM DISORDER; NUMERICAL MODEL; RODENT;

ANIMALIA;

ANIMAL; AUTISM; DISEASE MODEL; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; MOUSE; MUTATION; PHYSIOLOGY; SCHIZOPHRENIA; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; AUTISTIC DISORDER; DISEASE MODELS, ANIMAL; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MUTATION; SCHIZOPHRENIA;

EID: 85040948809     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2017.0037     Document Type: Review

References (164)

1. Kapur S, Phillips AG, Insel TR. 2012 Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol. Psychiatry 17, 1174–1179. (doi:10.1038/mp.2012.105)
2. Modabbernia A, Velthorst E, Reichenberg A. 2017 Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Mol. Autism 8, 13. (doi:10.1186/s13229-017-0121-4)
3. Opler M, Charap J, Greig A, Stein V, Polito S, Malaspina D. 2013 Environmental risk factors and schizophrenia. Int. J. Mental Health 42, 23–32. (doi:10.2753/IMH0020-7411420102)
4. Chisholm K, Lin A, Abu-Akel A, Wood SJ. 2015 The association between autism and schizophrenia spectrum disorders: a review of eight alternate models of co-occurrence. Neurosci. Biobehav. Rev. 55, 173–183. (doi:10.1016/j.neubiorev.2015. 04.012)
5. Hamlyn J, Duhig M, McGrath J, Scott J. 2013 Modifiable risk factors for schizophrenia and autism–shared risk factors impacting on brain development. Neurobiol. Dis. 53, 3–9. (doi:10. 1016/j.nbd.2012.10.023)
6. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. 2009 Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373, 234–239. (doi:10.1016/S0140-6736(09)60072-6)
7. Sullivan PF, Kendler KS, Neale MC. 2003 Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60, 1187–1192. (doi:10.1001/archpsyc.60.12.1187)
8. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M. 1995 Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25, 63–77. (doi:10.1017/S0033291700028099)
9. Ronald A, Hoekstra RA. 2011 Autism spectrum disorders and autistic traits: a decade of new twin studies. Am. J. Med. Genet. B 156B, 255–274. (doi:10.1002/ajmg.b.31159)
10. Millar JK et al. 2000 Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9, 1415–1423. (doi:10.1093/hmg/9.9.1415)
11. Schneider M et al. 2014 Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the international consortium on brain and behavior in 22q11.2 deletion syndrome. Am. J. Psychiatry 171, 627–639. (doi:10. 1176/appi.ajp.2013.13070864)
12. Richards RI, Sutherland GR. 1992 Dynamic mutations: a new class of mutations causing human disease. Cell 70, 709–712. (doi:10.1016/0092-8674(92)90302-S)
13. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999 Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185–188. (doi:10.1038/13810)
14. Jamain S et al. 2003 Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34, 27–29. (doi:10.1038/ng1136)
15. Wei WH, Hemani G, Haley CS. 2014 Detecting epistasis in human complex traits. Nat. Rev. Genet. 15, 722–733. (doi:10.1038/nrg3747)
16. Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF, Sklar P. 2009 Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752. (doi:10.1038/nature08185)
17. Conrad DF et al. 2010 Origins and functional impact of copy number variation in the human genome. Nature 464, 704–712. (doi:10.1038/nature08516)
18. Levy D et al. 2011 Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70, 886–897. (doi:10.1016/j. neuron.2011.05.015)
19. Sanders SJ et al. 2012 De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241. (doi:10.1038/nature10945)
20. Neale BM et al. 2012 Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242–245. (doi:10.1038/nature11011)
21. De Rubeis S et al. 2014 Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209–215. (doi:10.1038/nature13772)
22. Stefansson H et al. 2008 Large recurrent microdeletions associated with schizophrenia. Nature 455, 232–236. (doi:10.1038/nature07229)
23. Durand CM et al. 2007 Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39, 25–27. (doi:10.1038/ng1933)
24. Gauthier J et al. 2009 Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B 150B, 421–424. (doi:10.1002/ajmg.b.30822)
25. Bucan M et al. 2009 Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 5, e1000536. (doi:10.1371/journal. pgen.1000536)
26. Kim HG et al. 2008 Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 82, 199–207. (doi:10.1016/j. ajhg.2007.09.011)
27. Berkel S et al. 2010 Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 42, 489–491. (doi:10.1038/ng.589)
28. Fernandez T, Morgan T, Davis N, Klin A, Morris A, Farhi A, Lifton RP, State MW. 2004 Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am. J. Hum. Genet. 74, 1286–1293. (doi:10.1086/421474)
29. Fernandez T, Morgan T, Davis N, Klin A, Morris A, Farhi A, Lifton RP, State MW. 2008 Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am. J. Hum. Genet. 82, 1385. (doi:10.1016/j.ajhg.2008.04.021)
30. Glessner JT et al. 2009 Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459, 569–573. (doi:10.1038/nature07953)
31. Bakkaloglu B et al. 2008 Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet. 82, 165–173. (doi:10.1016/j. ajhg.2007.09.017)
32. Strauss KA, Puffenberger EG, Huentelman MJ, Gottlieb S, Dobrin SE, Parod JM, Stephan DA, Morton DH. 2006 Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med. 354, 1370–1377. (doi:10. 1056/NEJMoa052773)
33. Need AC, Goldstein DB. 2014 Schizophrenia genetics comes of age. Neuron 83, 760–763. (doi:10.1016/j. neuron.2014.08.015)
34. Harrison PJ. 2015 GABA circuitry, cells and molecular regulation in schizophrenia: life in the graveyard. Schizophr. Res. 167, 108–110. (doi:10. 1016/j.schres.2015.02.003)
35. Jablensky A. 2015 Schizophrenia or schizophrenias? The challenge of genetic parsing of a complex disorder. Am. J. Psychiatry 172, 105–107. (doi:10. 1176/appi.ajp.2014.14111452)
36. Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014 Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427. (doi:10.1038/nature13595)
37. Li Z et al. 2017 Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia. Nature Genetics 49, 1576–1583. (doi:10.1038/ng.3973)
38. Hannon E et al. 2016 Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat. Neurosci. 19, 48–54. (doi:10.1038/nn.4182)
39. Purcell SM et al. 2014 A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190. (doi:10.1038/nature12975)
40. Davidson S et al. 2011 Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism. Neuropsychopharmacology 36, 2211–2221. (doi:10.1038/npp.2011.93)
41. Hing B, Davidson S, Lear M, Breen G, Quinn J, McGuffin P, MacKenzie A. 2012 A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity. Biol. Psychiatry 71, 618–626. (doi:10. 1016/j.biopsych.2011.11.030)
42. Boyle EA, Li YI, Pritchard JK. 2017 An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177–1186. (doi:10.1016/j. cell.2017.05.038)
43. de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. 2016 Advancing the understanding of autism disease mechanisms through genetics. Nat. Med. 22, 345–361. (doi:10.1038/nm.4071)
44. McCammon JM, Sive H. 2015 Addressing the genetics of human mental health disorders in model organisms. Annu. Rev. Genomics Hum. Genet. 16, 173–197. (doi:10.1146/annurev-genom-090314-050048)
45. Silverman JL, Yang M, Lord C, Crawley JN. 2010 Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490–502. (doi:10. 1038/nrn2851)
46. Brennand KJ et al. 2011 Modelling schizophrenia using human induced pluripotent stem cells. Nature 473, 221–225. (doi:10.1038/nature09915)
47. Yoon KJ et al. 2014 Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity. Cell Stem Cell 15, 79–91. (doi:10.1016/j. stem.2014.05.003)
48. Pasca AM et al. 2015 Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods 12, 671–678. (doi:10. 1038/nmeth.3415)
49. Birey F et al. 2017 Assembly of functionally integrated human forebrain spheroids. Nature 545, 54–59. (doi:10.1038/nature22330)
50. Lancaster MA, Knoblich JA. 2014 Generation of cerebral organoids from human pluripotent stem cells. Nat. Protoc. 9, 2329–2340. (doi:10.1038/nprot.2014.158)
51. Lancaster MA et al. 2013 Cerebral organoids model human brain development and microcephaly. Nature 501, 373–379. (doi:10.1038/nature12517)
52. Kadoshima T, Sakaguchi H, Nakano T, Soen M, Ando S, Eiraku M, Sasai Y. 2013 Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell-derived neocortex. Proc. Natl. Acad. Sci. USA 110, 20 284–20 289. (doi:10.1073/pnas. 1315710110)
53. Watanabe K, Kamiya D, Nishiyama A, Katayama T, Nozaki S, Kawasaki H, Watanabe Y, Mizuseki K, Sasai Y. 2005 Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 8, 288–296. (doi:10.1038/nn1402)
54. Muguruma K, Nishiyama A, Kawakami H, Hashimoto K, Sasai Y. 2015 Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells. Cell Rep. 10, 537–550. (doi:10.1016/j.celrep.2014.12.051)
55. Ranga A, Girgin M, Meinhardt A, Eberle D, Caiazzo M, Tanaka EM, Lutolf MP. 2016 Neural tube morphogenesis in synthetic 3D microenvironments. Proc. Natl Acad. Sci. USA 113, E6831–E6839. (doi:10.1073/pnas.1603529113)
56. Davis SW, Mortensen AH, Keisler JL, Zacharias AL, Gage PJ, Yamamura K, Camper SA. 2016 Beta-catenin is required in the neural crest and mesencephalon for pituitary gland organogenesis. BMC Dev. Biol. 16, 16. (doi:10.1186/s12861-016-0118-9)
57. Sakaguchi H, Kadoshima T, Soen M, Narii N, Ishida Y, Ohgushi M, Takahashi J, Eiraku M, Sasai Y. 2015 Generation of functional hippocampal neurons from self-organizing human embryonic stem cell-derived dorsomedial telencephalic tissue. Nat. Commun. 6, 8896. (doi:10.1038/ncomms9896)
58. Eiraku M, Sasai Y. 2011 Mouse embryonic stem cell culture for generation of three-dimensional retinal and cortical tissues. Nat. Protoc. 7, 69–79. (doi:10. 1038/nprot.2011.429)
59. Kuwahara A, Ozone C, Nakano T, Saito K, Eiraku M, Sasai Y. 2015 Generation of a ciliary margin-like stem cell niche from self-organizing human retinal tissue. Nat. Commun. 6, 6286. (doi:10.1038/ncomms7286)
60. Tao Y, Zhou X, Liu D, Li H, Liang C, Li F, Chen Q. 2016 Proportion of collagen type II in the extracellular matrix promotes the differentiation of human adipose-derived mesenchymal stem cells into nucleus pulposus cells. Biofactors 42, 212–223. (doi:10.1002/biof.1266)
61. Marin O, Muller U. 2014 Lineage origins of GABAergic versus glutamatergic neurons in the neocortex. Curr. Opin. Neurobiol. 26, 132–141. (doi:10.1016/j.conb.2014.01.015)
62. Bartolini G, Ciceri G, Marin O. 2013 Integration of GABAergic interneurons into cortical cell assemblies: lessons from embryos and adults. Neuron 79, 849–864. (doi:10.1016/j.neuron.2013.08.014)
63. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N, Harrison NL, Studer L. 2004 Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA 101, 12 543– 12 548. (doi:10.1073/pnas.0404700101)
64. Li XJ, Du ZW, Zarnowska ED, Pankratz M, Hansen LO, Pearce RA, Zhang SC. 2005 Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 23, 215–221. (doi:10.1038/nbt1063)
65. Tabata H. 2015 Diverse subtypes of astrocytes and their development during corticogenesis. Front. Neurosci. 9, 114. (doi:10.3389/fnins.2015.00114)
66. Wang S et al. 2013 Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12, 252–264. (doi:10.1016/j.stem.2012.12.002)
67. Eiraku M et al. 2008 Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3, 519–532. (doi:10.1016/j.stem.2008.09.002)
68. Parr CJC, Yamanaka S, Saito H. 2017 An update on stem cell biology and engineering for brain development. Mol. Psychiatry 22, 808–819. (doi:10.1038/mp.2017.66)
69. van den Ameele J, Tiberi L, Vanderhaeghen P, Espuny-Camacho I. 2014 Thinking out of the dish: what to learn about cortical development using pluripotent stem cells. Trends Neurosci. 37, 334–342. (doi:10.1016/j.tins.2014.03.005)
70. Anderson S, Vanderhaeghen P. 2014 Cortical neurogenesis from pluripotent stem cells: complexity emerging from simplicity. Curr. Opin. Neurobiol. 27, 151–157. (doi:10.1016/j.conb.2014.03.012)
71. Qian X et al. 2016 Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165, 1238–1254. (doi:10.1016/j.cell.2016.04.032)
72. Vadivelu RK, Kamble H, Shiddiky MJA, Nguyen N-T. 2017 Microfluidic technology for the generation of cell spheroids and their applications. Micromachines 8, 94. (doi:10.3390/mi8040094)
73. Lancaster MA et al. 2017 Guided self-organization and cortical plate formation in human brain organoids. Nat. Biotechnol. 35, 659–666. (doi:10. 1038/nbt.3906)
74. Quadrato G et al. 2017 Cell diversity and network dynamics in photosensitive human brain organoids. Nature 545, 48–53. (doi:10.1038/nature22047)
75. Sekar A et al. 2016 Schizophrenia risk from complex variation of complement component 4. Nature 530, 177–183. (doi:10.1038/nature16549)
76. Boksa P. 2012 Abnormal synaptic pruning in schizophrenia: urban myth or reality? J. Psychiatry Neurosci. 37, 75–77. (doi:10.1503/jpn.120007)
77. Ripke S et al. 2013 Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150–1159. (doi:10.1038/ng.2742)
78. Pasca SP et al. 2011 Using iPSC-derived neurons to uncover cellular phenotypes associated with timothy syndrome. Nat. Med. 17, 1657–1662. (doi:10.1038/nm.2576)
79. Bortone D, Polleux F. 2009 KCC2 expression promotes the termination of cortical interneuron migration in a voltage-sensitive calcium-dependent manner. Neuron 62, 53–71. (doi:10.1016/j.neuron. 2009.01.034)
80. Gratten J, Visscher PM, Mowry BJ, Wray NR. 2013 Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease. Nat. Genet. 45, 234–238. (doi:10.1038/ng.2555)
81. Porteous DJ et al. 2014 DISC1 as a genetic risk factor for schizophrenia and related major mental illness: response to Sullivan. Mol. Psychiatry 19, 141–143. (doi:10.1038/mp.2013.160)
82. Brandon NJ, Sawa A. 2011 Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat. Rev. Neurosci. 12, 707–722. (doi:10.1038/nrn3120)
83. Clair S, Blackwood D, Muir D, Carothers W, Walker A, Spowart M, Gosden G, Evans HJ. 1990 Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336, 13–16. (doi:10.1016/0140-6736(90)91520-K)
84. Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ. 2001 Schizophrenia and affective disorders—cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 69, 428–433. (doi:10.1086/321969)
85. Guha S et al. 2013 Implication of a rare deletion at distal 16p11.2 in schizophrenia. JAMA Psychiatry 70, 253–260. (doi:10.1001/2013.jamapsychiatry.71)
86. Meyer KD, Morris JA. 2008 Immunohistochemical analysis of Disc1 expression in the developing and adult hippocampus. Gene Expr. Patterns 8, 494–501. (doi:10.1016/j.gep.2008.06.005)
87. Duan X et al. 2007 Disrupted-in-schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 130, 1146–1158. (doi:10. 1016/j.cell.2007.07.010)
88. Lipska BK et al. 2006 Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum. Mol. Genet. 15, 1245–1258. (doi:10.1093/hmg/ddl040)
89. Ozeki Y et al. 2003 Disrupted-in-schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc. Natl Acad. Sci. USA 100, 289–294. (doi:10. 1073/pnas.0136913100)
90. Miyoshi K, Honda A, Baba K, Taniguchi M, Oono K, Fujita T, Kuroda S, Katayama T, Tohyama M. 2003 Disrupted-in-schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol. Psychiatry 8, 685–694. (doi:10.1038/sj.mp. 4001352)
91. Kamiya A et al. 2005 A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol. 7, 1167–1178. (doi:10. 1038/ncb1328)
92. Tomoda T, Sumitomo A, Jaaro-Peled H, Sawa A. 2016 Utility and validity of DISC1 mouse models in biological psychiatry. Neuroscience 321, 99–107. (doi:10.1016/j.neuroscience.2015.12.061)
93. Shen S et al. 2008 Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J. Neurosci. 28, 10 893–10 904. (doi:10.1523/JNEUROSCI.3299-08.2008)
94. Niwa M et al. 2010 Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 65, 480–489. (doi:10. 1016/j.neuron.2010.01.019)
95. Yerabham ASK et al. 2017 A structural organization for the disrupted in schizophrenia 1 protein, identified by high-throughput screening, reveals distinctly folded regions, which are bisected by mental illness-related mutations. J. Biol. Chem. 292, 6468–6477. (doi:10.1074/jbc.M116.773903)
96. Sawamura N et al. 2008 Nuclear DISC1 regulates CRE-mediated gene transcription and sleep homeostasis in the fruit fly. Mol. Psychiatry 13, 1138–1148, 1069. (doi:10.1038/mp.2008.101)
97. Furukubo-Tokunaga K et al. 2016 Visualization of DISC1-Dysbindin interaction in glutamatergic synaptic termini in fruit flies. Mol. Psychiatry 21, 1157. (doi:10.1038/mp.2016.142)
98. Singh KK et al. 2011 Common DISC1 polymorphisms disrupt Wnt/GSK3beta signaling and brain development. Neuron 72, 545–558. (doi:10.1016/j. neuron.2011.09.030)
99. Srikanth P et al. 2015 Genomic DISC1 disruption in hiPSCs alters Wnt signaling and neural cell fate. Cell Rep. 12, 1414–1429. (doi:10.1016/j.celrep. 2015.07.061)
100. Chiang CH, Su Y, Wen Z, Yoritomo N, Ross CA, Margolis RL, Song H, Ming GL. 2011 Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol. Psychiatry 16, 358–360. (doi:10.1038/mp.2011.13)
101. Wen Z et al. 2014 Synaptic dysregulation in a human iPS cell model of mental disorders. Nature 515, 414–418. (doi:10.1038/nature13716)
102. Maher BJ, LoTurco JJ. 2012 Disrupted-in-schizophrenia (DISC1) functions presynaptically at glutamatergic synapses. PLoS ONE 7, e34053. (doi:10.1371/journal.pone.0034053)
103. Tang W, Thevathasan JV, Lin Q, Lim KB, Kuroda K, Kaibuchi K, Bilger M, Soong TW, Fivaz M. 2016 Stimulation of synaptic vesicle exocytosis by the mental disease gene DISC1 is mediated by N-type voltage-gated calcium channels. Front. Synaptic Neurosci. 8, 15. (doi:10.3389/fnsyn.2016.00015)
104. Crabtree GW et al. 2017 Alteration of neuronal excitability and short-term synaptic plasticity in the prefrontal cortex of a mouse model of mental illness. J. Neurosci. 37, 4158–4180. (doi:10.1523/JNEUROSCI.4345-15.2017)
105. Insel TR. 2010 Rethinking schizophrenia. Nature 468, 187–193. (doi:10.1038/nature09552)
106. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. 2003 White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 60, 443–456. (doi:10.1001/archpsyc.60. 5.443)
107. Kubicki M, McCarley RW, Shenton ME. 2005 Evidence for white matter abnormalities in schizophrenia. Curr. Opin. Psychiatry 18, 121–134. (doi:10.1097/00001504-200503000-00004)
108. Whalley HC et al. 2015 Effects of a balanced translocation between chromosomes 1 and 11 disrupting the disc1 locus on white matter integrity. PLoS ONE 10, e0130900. (doi:10.1371/journal.pone. 0130900)
109. Liu Y, Liu H, Sauvey C, Yao L, Zarnowska ED, Zhang SC. 2013 Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells. Nat. Protoc. 8, 1670–1679. (doi:10.1038/nprot. 2013.106)
110. Alkuraya FS et al. 2011 Human mutations in NDE1 cause extreme microcephaly with lissencephaly [corrected]. Am. J. Hum. Genet. 88, 536–547. (doi:10.1016/j.ajhg.2011.04.003)
111. Mefford HC et al. 2007 Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy. Am. J. Hum. Genet. 81, 1057–1069. (doi:10.1086/522591)
112. Ullmann R et al. 2007 Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum. Mutat. 28, 674–682. (doi:10.1002/humu.20546)
113. Williams NM et al. 2010 Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 376, 1401–1408. (doi:10.1016/S0140-6736(10)61109-9)
114. Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, Holmans P, Craddock N, Owen MJ, O’Donovan MC. 2009 Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum. Mol. Genet. 18, 1497–1503. (doi:10.1093/hmg/ddp043)
115. Ingason A et al. 2011 Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol. Psychiatry 16, 17–25. (doi:10. 1038/mp.2009.101)
116. Johnstone M et al. 2015 Copy number variations in DISC1 and DISC1-interacting partners in major mental illness. Mol. Neuropsychiatry 1, 175–190. (doi:10.1159/000438788)
117. Hennah W et al. 2007 Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. Hum. Mol. Genet. 16, 453–462. (doi:10.1093/hmg/ddl462)
118. Feng Y, Olson EC, Stukenberg PT, Flanagan LA, Kirschner MW, Walsh CA. 2000 LIS1 regulates CNS lamination by interacting with mNudE, a central component of the centrosome. Neuron 28, 665–679. (doi:10.1016/S0896-6273(00) 00145-8)
119. Efimov VP, Morris NR. 2000 The LIS1-related NUDF protein of Aspergillus nidulans interacts with the coiled-coil domain of the NUDE/RO11 protein. J. Cell Biol. 150, 681–688. (doi:10.1083/jcb.150.3.681)
120. Kitagawa M, Umezu M, Aoki J, Koizumi H, Arai H, Inoue K. 2000 Direct association of LIS1, the lissencephaly gene product, with a mammalian homologue of a fungal nuclear distribution protein, rNUDE. FEBS Lett. 479, 57–62. (doi:10.1016/S0014-5793(00)01856-1)
121. Niethammer M, Smith DS, Ayala R, Peng J, Ko J, Lee MS, Morabito M, Tsai LH. 2000 NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 28, 697–711. (doi:10. 1016/S0896-6273(00)00147-1)
122. Sasaki S et al. 2005 Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality. Mol. Cell. Biol. 25, 7812–7827. (doi:10. 1128/MCB.25.17.7812-7827.2005)
123. Yan X, Li F, Liang Y, Shen Y, Zhao X, Huang Q, Zhu X. 2003 Human Nudel and NudE as regulators of cytoplasmic dynein in poleward protein transport along the mitotic spindle. Mol. Cell. Biol. 23, 1239–1250. (doi:10.1128/MCB.23.4.1239-1250.2003)
124. Shu T, Ayala R, Nguyen MD, Xie Z, Gleeson JG, Tsai LH. 2004 Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron 44, 263–277. (doi:10.1016/j.neuron.2004.09.030)
125. Li J, Lee WL, Cooper JA. 2005 NudEL targets dynein to microtubule ends through LIS1. Nat. Cell Biol. 7, 686–690. (doi:10.1038/ncb1273)
126. Stehman SA, Chen Y, McKenney RJ, Vallee RB. 2007 NudE and NudEL are required for mitotic progression and are involved in dynein recruitment to kinetochores. J. Cell Biol. 178, 583–594. (doi:10. 1083/jcb.200610112)
127. Vergnolle MA, Taylor SS. 2007 Cenp-F links kinetochores to Ndel1/Nde1/Lis1/dynein microtubule motor complexes. Curr. Biol. 17, 1173–1179. (doi:10.1016/j.cub.2007.05.077)
128. Bradshaw NJ, Ogawa F, Antolin-Fontes B, Chubb JE, Carlyle BC, Christie S, Claessens A, Porteous DJ, Millar JK. 2008 DISC1, PDE4B, and NDE1 at the centrosome and synapse. Biochem. Biophys. Res. Commun. 377, 1091–1096. (doi:10.1016/j.bbrc. 2008.10.120)
129. Burdick KE et al. 2008 Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding. Hum. Mol. Genet. 17, 2462–2473. (doi:10. 1093/hmg/ddn146)
130. Lam C, Vergnolle MA, Thorpe L, Woodman PG, Allan VJ. 2010 Functional interplay between LIS1, NDE1 and NDEL1 in dynein-dependent organelle positioning. J. Cell Sci. 123, 202–212. (doi:10.1242/jcs.059337)
131. McKenney RJ, Vershinin M, Kunwar A, Vallee RB, Gross SP. 2010 LIS1 and NudE induce a persistent dynein force-producing state. Cell 141, 304–314. (doi:10.1016/j.cell.2010.02.035)
132. Shmueli A et al. 2010 Ndel1 palmitoylation: a new mean to regulate cytoplasmic dynein activity. EMBO J. 29, 107–119. (doi:10.1038/emboj. 2009.325)
133. Vallee RB, McKenney RJ, Ori-McKenney KM. 2012 Multiple modes of cytoplasmic dynein regulation. Nat. Cell Biol. 14, 224–230. (doi:10.1038/ncb2420)
134. Allan VJ. 2011 Cytoplasmic dynein. Biochem. Soc. Trans. 39, 1169–1178. (doi:10.1042/BST0391169)
135. Kardon JR, Vale RD. 2009 Regulators of the cytoplasmic dynein motor. Nat. Rev. Mol. Cell Biol. 10, 854–865. (doi:10.1038/nrm2804)
136. Hirotsune S, Fleck MW, Gambello MJ, Bix GJ, Chen A, Clark GD, Ledbetter DH, McBain CJ, Wynshaw-Boris A. 1998 Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat. Genet. 19, 333–339. (doi:10.1038/1221)
137. Paylor R, Hirotsune S, Gambello MJ, Yuva-Paylor L, Crawley JN, Wynshaw-Boris A. 1999 Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learn. Mem. 6, 521–537. (doi:10.1101/lm.6.5.521)
138. Feng Y, Walsh CA. 2004 Mitotic spindle regulation by Nde1 controls cerebral cortical size. Neuron 44, 279–293. (doi:10.1016/j.neuron.2004.09.023)
139. Bakircioglu M et al. 2011 The essential role of centrosomal NDE1 in human cerebral cortex neurogenesis. Am. J. Hum. Genet. 88, 523–535. (doi:10.1016/j.ajhg.2011.03.019)
140. Houlihan SL, Feng Y. 2014 The scaffold protein Nde1 safeguards the brain genome during S phase of early neural progenitor differentiation. eLife 3, e03297. (doi:10.7554/eLife.03297)
141. Doobin DJ, Kemal S, Dantas TJ, Vallee RB. 2016 Severe NDE1-mediated microcephaly results from neural progenitor cell cycle arrests at multiple specific stages. Nat. Commun. 7, 12551. (doi:10. 1038/ncomms12551)
142. Tropeano M et al. 2013 Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders. PLoS ONE 8, e61365. (doi:10.1371/journal.pone.0061365)
143. Kimura H et al. 2015 Identification of rare, single-nucleotide mutations in NDE1 and their contributions to schizophrenia susceptibility. Schizophr. Bull. 41, 744–753. (doi:10.1093/schbul/sbu147)
144. Tomppo L, Ekelund J, Lichtermann D, Veijola J, Jarvelin MR, Hennah W. 2012 DISC1 conditioned GWAS for psychosis proneness in a large Finnish birth cohort. PLoS ONE 7, e30643. (doi:10.1371/journal.pone.0030643)
145. Fietz SA et al. 2010 OSVZ progenitors of human and ferret neocortex are epithelial-like and expand by integrin signaling. Nat. Neurosci. 13, 690–699. (doi:10.1038/nn.2553)
146. Hansen DV, Lui JH, Parker PR, Kriegstein AR. 2010 Neurogenic radial glia in the outer subventricular zone of human neocortex. Nature 464, 554–561. (doi:10.1038/nature08845)
147. Malhotra D, Sebat J. 2012 CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 148, 1223–1241. (doi:10.1016/j.cell.2012.02.039)
148. Tam GW et al. 2010 Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem. Soc. Trans. 38, 445–451. (doi:10.1042/BST0380445)
149. Zhao Q et al. 2013 Rare CNVs and tag SNPs at 15q11.2 are associated with schizophrenia in the Han Chinese population. Schizophr. Bull. 39, 712–719. (doi:10.1093/schbul/sbr197)
150. Stefansson H et al. 2014 CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505, 361–366. (doi:10.1038/nature12818)
151. Kobayashi K et al. 1998 p140Sra-1 (specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase. J. Biol. Chem. 273, 291–295. (doi:10.1074/jbc.273.1.291)
152. Schenck A, Bardoni B, Moro A, Bagni C, Mandel JL. 2001 A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc. Natl Acad. Sci. USA 98, 8844–8849. (doi:10.1073/pnas.151231598)
153. Napoli I et al. 2008 The fragile ☓ syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134, 1042–1054. (doi:10. 1016/j.cell.2008.07.031)
154. Kunda P, Craig G, Dominguez V, Baum B. 2003 Abi, Sra1, and Kette control the stability and localization of SCAR/WAVE to regulate the formation of actin-based protrusions. Curr. Biol. 13, 1867–1875. (doi:10.1016/j.cub.2003.10.005)
155. Steffen A, Rottner K, Ehinger J, Innocenti M, Scita G, Wehland J, Stradal TE. 2004 Sra-1 and Nap1 link Rac to actin assembly driving lamellipodia formation. EMBO J. 23, 749–759. (doi:10.1038/sj.emboj.7600084)
156. Auerbach BD, Osterweil EK, Bear MF. 2011 Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68. (doi:10.1038/nature10658)
157. O’Roak BJ et al. 2012 Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246–250. (doi:10.1038/nature10989)
158. Zhou J, Brugarolas J, Parada LF. 2009 Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1. Hum. Mol. Genet. 18, 4428–4441. (doi:10.1093/hmg/ddp398)
159. Hoeffer CA et al. 2012 Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav. 11, 332–341. (doi:10.1111/j.1601-183X.2012.00768.x)
160. Kazdoba TM, Leach PT, Silverman JL, Crawley JN. 2014 Modeling fragile ☓ syndrome in the Fmr1 knockout mouse. Intractable Rare Dis. Res. 3, 118– 133. (doi:10.5582/irdr.2014.01024).
161. Yonan AL et al. 2003 A genomewide screen of 345 families for autism-susceptibility loci. Am. J. Hum. Genet. 73, 886–897. (doi:10.1086/378778)
162. Neves-Pereira M, Muller B, Massie D, Williams JH, O’Brien PC, Hughes A, Shen SB, Clair DS, Miedzybrodzka Z. 2009 Deregulation of EIF4E: a novel mechanism for autism. J. Med. Genet. 46, 759–765. (doi:10.1136/jmg.2009. 066852)
163. Gkogkas CG et al. 2013 Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature 493, 371–377. (doi:10.1038/nature11628)
164. Santini E, Huynh TN, MacAskill AF, Carter AG, Pierre P, Ruggero D, Kaphzan H, Klann E. 2013 Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature 493, 411–415. (doi:10.1038/nature11782)